Abstract：Objective To analyze the trends in incidence and mortality of prostate cancer in Jinhua City, Zhejiang Province from 2016 to 2024, so as to provide the evidence for the improvement of prostate cancer prevention and control measures. Methods The incidence and mortality data of prostate cancer in Jinhua City from 2016 to 2024 were collected from the Chronic Disease Surveillance Information Management System of Zhejiang Province, and the crude incidence and mortality were calculated. The Chinese Sixth National Population Census in 2010 was used to calculate standardized incidence and mortality. The trends in incidence and mortality of prostate cancer were evaluated using average annual percent change (AAPC). Results A total of 8 357 cases of prostate cancer were diagnosed in Jinhua City from 2016 to 2024. The crude incidence and standardized incidence were 37.36/105 and 21.17/105, respectively, showing upward trends (AAPC=16.275%, 12.511%, both P<0.05). There were 1 615 deaths of prostate cancer, and the crude mortality was 7.22/105, showing an upward trend (AAPC=5.451%, P<0.05). The standardized mortality was 3.49/105, and the trend showed no statistically significant (P>0.05). There were 28 cases of prostate cancer in individuals under 50 years old, accounting for 0.34%. The crude incidence and crude mortality of patients aged ≥50 years increased with age (both P<0.05). From 2016 to 2024, the crude incidence of prostate cancer in the 50-<60, 60-<70, 70-<80, and ≥80 age groups showed upward trends (AAPC=17.849%, 14.704%, 12.654% and 8.081%, all P<0.05), and the 50-<60 age group increased more quickly. There was no significant change in the crude mortality of prostate cancer among different age groups (all P>0.05). Conclusion From 2016 to 2024, the incidence of prostate cancer in Jinhua City showed an upward trend and had a trend of becoming younger, while the mortality remained relatively stable.
陈梦倩, 王小红, 周凡, 张小兰, 徐则林. 2016—2024年金华市前列腺癌发病和死亡趋势分析[J]. 预防医学, 2025, 37(10): 1035-1038.
CHEN Mengqian, WANG Xiaohong, ZHOU Fan, ZHANG Xiaolan, XU Zelin. Trends in incidence and mortality of prostate cancer in Jinhua City from 2016 to 2024. Preventive Medicine, 2025, 37(10): 1035-1038.
[1] BRAY F,LAVERSANNE M,SUNG H,et al.Global cancer statistics 2022:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2024,74(3):229-263. [2] 郑荣寿,陈茹,韩冰峰,等.2022年中国恶性肿瘤流行情况分析[J].中华肿瘤杂志,2024,46(3):221-231. ZHENG R S,CHEN R,HAN B F,et al.Cancer incidence and mortality in China,2022[J].Chin J Oncol,2024,46(3):221-231.(in Chinese) [3] 王悠清,李辉章,龚巍巍,等.2015年浙江省肿瘤登记地区恶性肿瘤发病与死亡分析[J].中国肿瘤,2019,28(1):12-22. WANG Y Q,LI H Z,GONG W W,et al.Analysis of cancer incidence and mortality in Zhejiang cancer registries,2015[J].China Cancer,2019,28(1):12-22.(in Chinese) [4] 朱洪挺,胡云卿,李辉章,等.2010—2014年浙江省肿瘤登记地区前列腺癌发病与死亡分析[J].中国肿瘤,2019,28(2):110-114. ZHU H T,HU Y Q,LI H Z,et al.Incidence and mortality of prostate cancer in Zhejiang cancer registration areas,2010-2014[J].China Cancer,2019,28(2):110-114.(in Chinese) [5] 闵淑慧,胡依,郭芮绮,等.1990—2019年中国前列腺癌疾病负担分析及趋势预测[J].中国肿瘤,2023,32(3):171-177. MIN S H,HU Y,GUO R Q,et al.Analysis of disease burden of prostate cancer in China from 1990 to 2019 and trend prediction[J].China Cancer,2023,32(3):171-177.(in Chinese) [6] 章群,王永,陈洁平,等.2011—2023年宁波市前列腺癌发病和死亡趋势分析[J].预防医学,2025,37(1):46-50. ZHANG Q,WANG Y,CHEN J P,et al.Trends in incidence and mortality of prostate cancer in Ningbo City from 2011 to 2023[J].China Prev Med J,2025,37(1):46-50.(in Chinese) [7] HAN B F,ZHENG R S,ZENG H M,et al.Cancer incidence and mortality in China,2022[J].J Natl Cancer Cent,2024,4(1):47-53. [8] 赵俊峰,何丽华,李为翊,等.2002—2019年黄浦区前列腺癌发病和死亡趋势[J].预防医学,2024,36(10):878-881,886. ZHAO J F,HE L H,LI W Y,et al.Trends in incidence and mortality of prostate cancer in Huangpu District from 2002 to 2019[J].China Prev Med J,2024,36(10):878-881,886.(in Chinese) [9] 孙金义,严亚琼,郭燕,等.2010—2019年武汉市前列腺癌疾病负担分析及死亡率预测[J].公共卫生与预防医学,2024,35(1):39-44. SUN J Y,YAN Y Q,GUO Y,et al.Disease burden and mortality forecast of prostate cancer in Wuhan in 2010-2019[J].J Public Health Prev Med,2024,35(1):39-44.(in Chinese) [10] 董娟,孔虹倩,文洪梅,等.云南省肿瘤登记地区2020年前列腺癌发病和死亡情况及2012—2020年趋势分析[J].实用肿瘤学杂志,2024,38(6):383-387. DONG J,KONG H Q,WEN H M,et al.Analysis of the prostate cancer incidence and mortality in cancer registration areas of Yunnan province in 2020 and the trend from 2012 to 2020[J].Pract Oncol J,2024,38(6):383-387.(in Chinese) [11] 刘硕,王硕,李慧超,等.2000—2017年北京市前列腺癌发病和死亡流行趋势及发病年龄变化特征分析[J].中国肿瘤,2021,30(7):495-505. LIU S,WANG S,LI H C,et al.Analysis on the trends of incidence,mortality and characteristics of age of onset for prostate cancer in Beijing,2000-2017[J].China Cancer,2021,30(7):495-505.(in Chinese) [12] 刘阳阳,王梁,刘志宇.前列腺癌相关危险因素的研究进展[J].泌尿外科杂志(电子版),2022,14(3):8-14. LIU Y Y,WANG L,LIU Z Y.Advances in the study of risk factors associated with prostate cancer[J].J Urol Clin(Electron Version),2022,14(3):8-14.(in Chinese) [13] 王永兴,姜永光,罗勇,等.前列腺癌患者年龄与临床病理特征的相关性[J].现代泌尿外科杂志,2019,24(8):621-624. WANG Y X,JIANG Y G,LUO Y,et al.Clinicopathological features of prostate cancer in different ages[J].J Mod Urol,2019,24(8):621-624.(in Chinese) [14] 中国抗癌协会泌尿男生殖系统肿瘤专业委员会前列腺癌学组.前列腺癌筛查中国专家共识(2021年版)[J].中国癌症杂志,2021,31(5):435-440. Prostate Cancer Group,Urological and Male Reproductive System Tumor Committee,China Anti-Cancer Association.China expert consensus on prostate cancer screening(2021 edition)[J].China Oncol,2021,31(5):435-440.(in Chinese)
